Crystalline adduct of moxifloxacin with trans-cinnamic acid to reduce the aqueous solubility and dissolution rate for improved residence time in the lungs Article

Eedara, Basanth Babu, Tucker, Ian G, Zujovic, Zoran D et al. (2019). Crystalline adduct of moxifloxacin with trans-cinnamic acid to reduce the aqueous solubility and dissolution rate for improved residence time in the lungs . 136 10.1016/j.ejps.2019.104961

International Collaboration

cited authors

  • Eedara, Basanth Babu; Tucker, Ian G; Zujovic, Zoran D; Rades, Thomas; Price, Jason R; Das, Shyamal C

sustainable development goals

authors

publication date

  • August 1, 2019

webpage

keywords

  • ABSORPTION
  • Crystalline adduct
  • DELIVERY
  • DRUGS
  • Dissolution
  • FORMULATIONS
  • Life Sciences & Biomedicine
  • METABOLISM
  • Moxifloxacin
  • PHARMACEUTICAL COCRYSTALS
  • PHARMACOKINETICS
  • PYRAZINAMIDE
  • Pharmacology & Pharmacy
  • Respirable particle
  • SOLID-STATE NMR
  • SPECTROSCOPY
  • Science & Technology
  • Solubility
  • Trans-cinnamic acid
  • Tuberculosis

Digital Object Identifier (DOI)

publisher

  • ELSEVIER

volume

  • 136